Martin Weltman

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

Shivakumar Chitturi, Shehan Abeygunasekera, Geoffrey C. Farrell et al. · Hepatology · 2002 · 1.1K citations

Metabolic Disorder, Insulin Resistance Syndrome, Insulin Hypersecretion +23

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

Martin Weltman, Geoffrey C. Farrell, Pauline de la Μ. Hall et al. · Hepatology · 1998 · 610 citations · Full text

Immunology, Gastroenterology, Pathology +20

The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study

Natasha A. Koloski, Michael Jones, Jamshid S. Kalantar et al. · Gut · 2012 · 583 citations

Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction

Michelle M. Richardson, Julie R. Jonsson, Elizabeth E. Powell et al. · Gastroenterology · 2007 · 477 citations · Full text

Metabolic Associated Steatohepatitis, Fibrosis, Hepatology +14